Cargando…
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
OBJECTIVE: To evaluate the efficacy of temozolomide (TMZ) chemotherapy for recurrent anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA). METHODS: A multi-center retrospective trial enrolled seventy-two patients with histologically proven AO/AOA who underwent TMZ chemotherapy for...
Autores principales: | Gwak, Ho-Shin, Yee, Gi Taek, Park, Chul-Kee, Kim, Jin Wook, Hong, Yong-Kil, Kang, Seok-Gu, Kim, Jeong Hoon, Seol, Ho Jun, Jung, Tae-Young, Chang, Jong Hee, Yoo, Heon, Hwang, Jeong-Hyun, Kim, Se-Hyuk, Park, Bong Jin, Hwang, Sun-Chul, Kim, Min Su, Kim, Seon-Hwan, Kim, Eun-Young, Kim, Ealmaan, Kim, Hae Yu, Ko, Young-Cho, Yun, Hwan Jung, Youn, Ji Hye, Kim, Juyoung, Lee, Byeongil, Lee, Seung Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Neurosurgical Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921276/ https://www.ncbi.nlm.nih.gov/pubmed/24527191 http://dx.doi.org/10.3340/jkns.2013.54.6.489 |
Ejemplares similares
-
Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases
por: Kim, Jo-Heon, et al.
Publicado: (2019) -
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017) -
Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases
por: Shin, Dong-Won, et al.
Publicado: (2020) -
Determination of the area at risk using quantitative T2 mapping in re-perfused myocardial infarction; a comparison with late gadolinium enhancement and CINE imaging
por: Kim, Tae Hoon, et al.
Publicado: (2013) -
The Role of Chemotherapy in Anaplastic Astrocytoma Patients
por: Kim, Sung Kwon, et al.
Publicado: (2012)